Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer

Breast cancer (BC) is the most diagnosed cancer in women worldwide. In estrogen receptor (ER)-positive disease, anti-estrogens and aromatase inhibitors (AI) improve patient survival; however, many patients develop resistance. Dysregulation of apoptosis is a common resistance mechanism; thus, agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamarbide Losada, J N, Sulpice, E, Combe, S, Almeida, G S, Leach, D A, Choo, J, Protopapa, L, Hamilton, M P, McGuire, S, Gidrol, X, Bevan, C L, Fletcher, C E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986394/
https://www.ncbi.nlm.nih.gov/pubmed/36622663
http://dx.doi.org/10.1530/JOE-22-0229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986394/
https://www.ncbi.nlm.nih.gov/pubmed/36622663
http://dx.doi.org/10.1530/JOE-22-0229

Ejemplares similares